NASDAQ
PRVA
Last Price
US $21.76
KEY FIGURES
MKT CAP
$2.7B
EPS
TTM
$0.22
EPS Growth (1Y)
63.64%
PEG
TTM
-
P/E
TTM
97.58x
P/S
TTM
1.16x
YIELD
-
GROWTH (5Y CAGR)
Revenue
Valuation
Financial
Performance
Cash flow to debt coverage
Privia Health Group, Inc. cash flow to debt ratio of 1.71K% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Free cash flow growth
Privia Health Group, Inc.'s free cash flow has increased 55.57% from $104.26M last year to $162.20M, signaling increasing performance
Debt-to-equity ratio
Privia Health Group, Inc.'s debt to equity ratio is 0.01, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
Privia Health Group, Inc.'s debt has increased relative to shareholder equity from 0.01 last year to 0.01 today, signaling weakened financials
Net debt to EBITDA
Privia Health Group, Inc. has a net cash position, so leverage is healthy.
Interest coverage
Privia Health Group, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.
Profit margin growth
Privia Health Group, Inc.'s profit margin has increased (43.97%) in the last year from 0.83% to 1.19%, signaling increasing performance
Current ratio
Privia Health Group, Inc.'s short-term assets of $911.00M exceed its short-term liabilities of $568.52M
Return on assets
Privia Health Group, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Privia Health Group, Inc.'s return on equity of 0.01%, is lower than 15.00%, indicating bad performance
Earnings quality
Privia Health Group, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Earnings stability
Privia Health Group, Inc. had positive net income in 3 out of 5 years, indicating stable and consistent earnings
Positive free cash flow
Privia Health Group, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Free cash flow yield
Privia Health Group, Inc. has a free cash flow yield of 5.75%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Earnings growth
Privia Health Group, Inc.'s yearly earnings has increased 59.33% since last year from $14.38M to $22.92M, signaling increasing performance
Revenue growth
Privia Health Group, Inc.'s yearly revenue has increased 22.26% since last year from $1.74B to $2.12B, signaling increasing performance
Return on invested capital
ROIC 0.00% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
Privia Health Group, Inc.'s 3-year revenue CAGR of 16.10% is positive, indicating growing revenue over the past 3 years
Revenue consistency
Privia Health Group, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance
Return on equity consistency
Privia Health Group, Inc. had positive ROE in 3 out of 5 years, indicating consistent and reliable returns on equity
Cash Flow Valuation (DCF)
Privia Health Group, Inc. is undervalued relative to its fair value price of 27.08 based on Discounted Cash Flow model
Earnings yield (TTM)
Privia Health Group, Inc. has an earnings yield of 1.00%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings
EBITDA Valuation
Privia Health Group, Inc. is overvalued relative to its fair value price of 6.30 based on EBITDA multiple model
EV/EBITDA (FY)
Privia Health Group, Inc. has an EV/EBITDA ratio of 43.62x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings
PEG ratio (TTM/FY)
Privia Health Group, Inc.'s earnings growth over the measurement period is negative; the PEG ratio is not meaningful and the check fails.
Price-to-book ratio (FY)
Privia Health Group, Inc. has a price-to-book ratio of 0.00x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
Privia Health Group, Inc. has a price-to-sales ratio of 1.20x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
0.01%
Return on equity
ROIC: 0%
Valuation History
96.8X
Price to Earnings
EV/EBITDA: -5878.7X
Cash flow
Profit margin
21.04%
EBITDA
14.62%
Cash flow
33.32%
Cash Flow (DCF)
Fair Value
Market $21.76
24.45%
Default assumptions
EBITDA Multiple
Fair Value
Market $21.76
-71.05%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.